MedTrace Logo

Ultra-sound for AAA Screening in Smoking Israeli Arab Men

NCT02306304 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 913

Last updated 2017-02-09

No results posted yet for this study

Summary

The study aims at screening Israeli Arab men, smokers or past smokers, for abdominal aortic aneurysms (AAA).

The screening is to be performed at the family doctors clinics in the rural arab erea of the north of Israel.

Goals:

The investigators aim at revealing the actual prevalence of AAA in the Israeli Arab smoking men population. By revealing this prevalence we believe the need for a nation-wide screening program for AAA will turn available for assessment.

In addition, the goal of improving the accessibility of health services for the Israeli Arab population is a key issue in the design of the research.

2000 patients are to be enrolled in the study over a period of 2 years. Each of the patients will be examined once for a duplex ultra-sound and will be classified into one of 4 sub-groups according to the maximal aortic diameter found.

Conditions

  • Abdominal Aortic Aneurysm (AAA)

Interventions

OTHER

Duplex ultra sound screening for abdominal aortic aneurysms

Duplex ultra sound screening for abdominal aortic aneurysms in Israeli Arab men, smokers or past smokers at the age of 60-80 years.

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Clalit Health Services

    lead OTHER

Principal Investigators

  • Asaf Rabin, M.D. · Clalit Heath Services

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
60 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2017-01-31
Completion
2017-01-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02306304 on ClinicalTrials.gov